DOCSLIB.ORG

2159-8290.CD-17-1203.Full-Text.Pdf

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
2159-8290.CD-17-1203.Full-Text.Pdf Author Manuscript Published OnlineFirst on August 23, 2018; DOI: 10.1158/2159-8290.CD-17-1203 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. 1 Title: Pathobiologic Pseudohypoxia as a Putative Mechanism Underlying Myelodysplastic Syndromes 2 3 Running title: Activation of HIF1A Signaling by Pseudohypoxia in MDS 4 5 Yoshihiro Hayashi1,16*, Yue Zhang2,17*, Asumi Yokota1*, Xiaomei Yan1, Jinqin Liu2, Kwangmin Choi1, 6 Bing Li2, Goro Sashida3, Yanyan Peng4, Zefeng Xu2, Rui Huang1, Lulu Zhang1, George M. Freudiger1, 7 Jingya Wang2, Yunzhu Dong1, Yile Zhou1, Jieyu Wang1, Lingyun Wu1,5, Jiachen Bu1,6, Aili Chen6, 8 Xinghui Zhao1, Xiujuan Sun2, Kashish Chetal7, Andre Olsson8, Miki Watanabe1, Lindsey E. Romick- 9 Rosendale1, Hironori Harada9, Lee-Yung Shih10, William Tse11, James P. Bridges12, Michael A. 10 Caligiuri13, Taosheng Huang4, Yi Zheng1, David P. Witte1, Qian-fei Wang6, Cheng-Kui Qu14, Nathan 11 Salomonis7, H. Leighton Grimes1,8, Stephen D. Nimer15, Zhijian Xiao2,18, and Gang Huang1,2,18 12 13 1 Divisions of Pathology and Experimental Hematology and Cancer Biology, Cincinnati Children’s 14 Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, Ohio 45229, USA 15 2 State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases 16 Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, 17 China 18 3 International Research Center for Medical Sciences, Kumamoto University, 2-2-1 Honjo, Chuo-ku, 19 Kumamoto 860-0811, Japan 20 4 Division of Human Genetics, Cincinnati Children’s Hospital Medical Center, 3333 Burnet Avenue, 21 Cincinnati, OH 45229, USA 22 5 Department of Hematology, Sixth Hospital Affiliated to Shanghai Jiaotong University, Shanghai 23 200233, China 1 Downloaded from cancerdiscovery.aacrjournals.org on September 25, 2021. © 2018 American Association for Cancer Research. Author Manuscript Published OnlineFirst on August 23, 2018; DOI: 10.1158/2159-8290.CD-17-1203 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. 24 6 Key Laboratory of Genomic and Precision Medicine, Collaborative Innovation Center of Genetics and 25 Development, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100101, China. 26 7 Division of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, 3333 Burnet 27 Avenue, Cincinnati, Ohio 45229, USA 28 8 Division of Immunobiology, Cincinnati Children’s Hospital Medical Center, 3333 Burnet Avenue, 29 Cincinnati, Ohio 45229, USA 30 9 Laboratory of Oncology, School of Life Science, Tokyo University of Pharmacy and Life Sciences, 31 Tokyo 192-0392, Japan 32 10 Department of Hematology and Oncology, Chang Gung Memorial Hospital-Linkou and Chang Gung 33 University College of Medicine, Taoyuan, Taiwan 34 11 James Graham Brown Cancer Center, University of Louisville Hospital, Louisville, Kentucky 40202, 35 USA 36 12 Division of Pulmonary Biology, Cincinnati Children’s Hospital Medical Center, 3333 Burnet Avenue, 37 Cincinnati, Ohio 45229, USA 38 13 The Ohio State University Comprehensive Cancer Center, Columbus, Ohio 43201, USA 39 14 Division of Hematology/Oncology, Aflac Cancer and Blood Disorders Center, Emory University 40 School of Medicine, Atlanta, GA 30322, USA 41 15 Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL 33136, USA 42 16 Present address: Laboratory of Oncology, School of Life Science, Tokyo University of Pharmacy and 43 Life Sciences, Tokyo 192-0392, Japan 44 17 Present address: Henan University of Chinese Medicine, Henan 450046, China 45 18 These authors jointly supervised this work. 46 * These authors contributed equally to this work. 2 Downloaded from cancerdiscovery.aacrjournals.org on September 25, 2021. © 2018 American Association for Cancer Research. Author Manuscript Published OnlineFirst on August 23, 2018; DOI: 10.1158/2159-8290.CD-17-1203 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. 47 48 The authors declare no potential conflicts of interest. 49 50 CORRESPONDING AUTHOR: 51 Correspondence and requests for materials should be addressed to ZJ.X. ([email protected]) or G.H. 52 ([email protected]). 53 54 LEAD CONTACT : Gang Huang, Ph.D. 55 Divisions of Pathology and Experimental Hematology and Cancer Biology, 56 Cincinnati Children's Hospital Medical Center, 57 3333 Burnet Avenue, Room S7.607, Cincinnati, Ohio 45229-3039, USA 58 Phone: (513) 636-3214, Fax: (513) 636-3768, Email: [email protected] 59 60 61 ABSTRACT: 62 Myelodysplastic syndromes (MDS) are heterogeneous hematopoietic disorders that are incurable with 63 conventional therapy. The incidence is increasing with global population ageing. Although many genetic, 64 epigenetic, splicing, and metabolic aberrations have been identified in MDS patients, their clinical 65 features are quite similar. Here we show that hypoxia-independent activation of hypoxia-inducible factor 66 1α (HIF1A) signaling is both necessary and sufficient to induce dysplastic and cytopenic MDS 67 phenotypes. The HIF1A transcriptional signature is generally activated in MDS-patient bone-marrow 68 stem/progenitors. Major MDS-associated mutations (Dnmt3a, Tet2, Asxl1, Runx1, and Mll1) activate the 69 HIF1A signature. While inducible activation of HIF1A signaling in hematopoietic cells is sufficient to 3 Downloaded from cancerdiscovery.aacrjournals.org on September 25, 2021. © 2018 American Association for Cancer Research. Author Manuscript Published OnlineFirst on August 23, 2018; DOI: 10.1158/2159-8290.CD-17-1203 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. 70 induce MDS phenotypes, both genetic and chemical inhibition of HIF1A signaling rescues MDS 71 phenotypes in a mouse model of MDS. These findings reveal HIF1A as a central pathobiologic mediator 72 of MDS, and as an effective therapeutic target for a broad spectrum of MDS patients. 73 74 SIGNIFICANCE: 75 We showed that dysregulation of HIF1A signaling could generate the clinically-relevant diversity of 76 MDS phenotypes by functioning as a signaling funnel for MDS driver-mutations. This could resolve the 77 disconnection between genotypes and phenotypes, and provide a new clue as to how a variety of driver- 78 mutations cause common MDS phenotypes. 79 80 INTRODUCTION: 81 MDS are a group of heterogeneous clonal disorders which are characterized by ineffective 82 hematopoiesis and uni- or multi-lineage dysplasia (1,2). Because of its diversity and complexity, the 83 pathogenesis of MDS remains to be elucidated. Limited preclinical models are available for dissecting 84 the pathogenesis and testing new drugs, and each model has its limitation (3,4). Stem cell transplantation 85 is a curative strategy for MDS, however, few patients are eligible for transplantation. Further elucidation 86 of the pathogenesis of MDS and development of novel therapeutic strategies are needed. MDS are 87 associated with mutations in chromatin-modifying enzymes, splicing factors, transcription factors, 88 cohesin complex, and metabolic enzymes that regulate hematopoietic stem cell (HSC) self-renewal, 89 survival, and differentiation. Cooperating genetic lesions occur, involving signaling molecules that 90 regulate cell growth and proliferation (1,2,5). Although a number of heterogeneous genomic aberrations 91 have been identified in MDS patients (6,7), their key clinical phenotypes are similar. Therefore, we 92 hypothesized that driver mutations activate common underlying mechanisms involved in MDS 4 Downloaded from cancerdiscovery.aacrjournals.org on September 25, 2021. © 2018 American Association for Cancer Research. Author Manuscript Published OnlineFirst on August 23, 2018; DOI: 10.1158/2159-8290.CD-17-1203 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. 93 phenotypes. Identification of these key mediators would reveal fundamental insights into MDS 94 pathogenesis, and present novel opportunities for therapeutic intervention beyond specific mutations or 95 aberrance for MDS. 96 Hypoxia inducible factor-1α (HIF1A) is a critical transcription factor for the hypoxic response, 97 angiogenesis, normal HSC regulation, and cancer development (8,9). Importantly, HIF1A is also 98 essential for the activation of innate and adaptive immunity (10). HIF1A is regulated by both oxygen- 99 dependent and oxygen-independent ways (11). HSCs and progenitor cells (HSPCs) isolated from MDS 100 patients display abnormal self-renewal and differentiation, and accumulating clinical and research 101 evidence suggests an important role for systemic inflammation and immune activation in MDS 102 pathogenesis (12). Thus, we tested the impact of HIF1A signaling in MDS. 103 104 RESULTS: 105 Activated HIF1A Pathway in the Broad Spectrum of MDS Patients 106 HIF1A is mainly regulated at translational and protein levels. Thus, analyzing downstream HIF1A- 107 signature-gene expression is a reliable approach to measure HIF1A activation. To determine whether 108 MDS patients have an activated HIF1A gene signature, we analyzed a published cohort of CD34+ BM 109 cells isolated from healthy donors (n = 17) or from MDS patients (n = 183) (13). This MDS cohort 110 contains patients with refractory anemia (RA) (n = 55), refractory anemia with ring sideroblasts (RARS) 111 (n = 48), refractory anemia with excess blast type 1 (RAEB1) (n = 37), or type 2 (RAEB2) (n = 43). 112
Load more

Recommended publications
  • FK506-Binding Protein 12.6/1B, a Negative Regulator of [Ca2+], Rescues Memory and Restores Genomic Regulation in the Hippocampus of Aging Rats
    This Accepted Manuscript has not been copyedited and formatted. The final version may differ from this version. A link to any extended data will be provided when the final version is posted online. Research Articles: Neurobiology of Disease FK506-Binding Protein 12.6/1b, a negative regulator of [Ca2+], rescues memory and restores genomic regulation in the hippocampus of aging rats John C. Gant1, Eric M. Blalock1, Kuey-Chu Chen1, Inga Kadish2, Olivier Thibault1, Nada M. Porter1 and Philip W. Landfield1 1Department of Pharmacology & Nutritional Sciences, University of Kentucky, Lexington, KY 40536 2Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL 35294 DOI: 10.1523/JNEUROSCI.2234-17.2017 Received: 7 August 2017 Revised: 10 October 2017 Accepted: 24 November 2017 Published: 18 December 2017 Author contributions: J.C.G. and P.W.L. designed research; J.C.G., E.M.B., K.-c.C., and I.K. performed research; J.C.G., E.M.B., K.-c.C., I.K., and P.W.L. analyzed data; J.C.G., E.M.B., O.T., N.M.P., and P.W.L. wrote the paper. Conflict of Interest: The authors declare no competing financial interests. NIH grants AG004542, AG033649, AG052050, AG037868 and McAlpine Foundation for Neuroscience Research Corresponding author: Philip W. Landfield, [email protected], Department of Pharmacology & Nutritional Sciences, University of Kentucky, 800 Rose Street, UKMC MS 307, Lexington, KY 40536 Cite as: J. Neurosci ; 10.1523/JNEUROSCI.2234-17.2017 Alerts: Sign up at www.jneurosci.org/cgi/alerts to receive customized email alerts when the fully formatted version of this article is published.
    [Show full text]
  • Transcriptional Events Co-Regulated by Hypoxia and Cold Stresses In
    Long et al. BMC Genomics (2015) 16:385 DOI 10.1186/s12864-015-1560-y RESEARCH ARTICLE Open Access Transcriptional events co-regulated by hypoxia and cold stresses in Zebrafish larvae Yong Long1, Junjun Yan1,2, Guili Song1, Xiaohui Li1,2, Xixi Li1,2, Qing Li1* and Zongbin Cui1* Abstract Background: Hypoxia and temperature stress are two major adverse environmental conditions often encountered by fishes. The interaction between hypoxia and temperature stresses has been well documented and oxygen is considered to be the limiting factor for the thermal tolerance of fish. Although both high and low temperature stresses can impair the cardiovascular function and the cross-resistance between hypoxia and heat stress has been found, it is not clear whether hypoxia acclimation can protect fish from cold injury. Results: Pre-acclimation of 96-hpf zebrafish larvae to mild hypoxia (5% O2) significantly improved their resistance to lethal hypoxia (2.5% O2) and increased the survival rate of zebrafish larvae after lethal cold (10°C) exposure. However, pre-acclimation of 96-hpf larvae to cold (18°C) decreased their tolerance to lethal hypoxia although their ability to endure lethal cold increased. RNA-seq analysis identified 132 up-regulated and 41 down-regulated genes upon mild hypoxia exposure. Gene ontology enrichment analyses revealed that genes up-regulated by hypoxia are primarily involved in oxygen transport, oxidation-reduction process, hemoglobin biosynthetic process, erythrocyte development and cellular iron ion homeostasis. Hypoxia-inhibited genes are enriched in inorganic anion transport, sodium ion transport, very long-chain fatty acid biosynthetic process and cytidine deamination. A comparison with the dataset of cold-regulated gene expression identified 23 genes co-induced by hypoxia and cold and these genes are mainly associated with oxidation-reduction process, oxygen transport, hemopoiesis, hemoglobin biosynthetic process and cellular iron ion homeostasis.
    [Show full text]
  • Neuronal Vulnerability and Multilineage Diversity in Multiple Sclerosis
    Europe PMC Funders Group Author Manuscript Nature. Author manuscript; available in PMC 2020 January 17. Published in final edited form as: Nature. 2019 June 13; 573(7772): 75–82. doi:10.1038/s41586-019-1404-z. Europe PMC Funders Author Manuscripts Neuronal vulnerability and multilineage diversity in multiple sclerosis Lucas Schirmer#1,2,3,4, Dmitry Velmeshev#1,5, Staffan Holmqvist2, Max Kaufmann6, Sebastian Werneburg7, Diane Jung1,5, Stephanie Vistnes1,4, John H. Stockley2, Adam Young8, Maike Steindel2,8, Brian Tung1,5,9, Nitasha Goyal1,5,9, Aparna Bhaduri1,5, Simone Mayer1,5, Jan Broder Engler6, Omer A. Bayraktar2, Robin J. M. Franklin8, Maximilian Haeussler10, Richard Reynolds11, Dorothy P. Schafer7, Manuel A. Friese6, Lawrence R. Shiow1,4, Arnold R. Kriegstein1,5,†, David H. Rowitch1,2,4,† 1Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco, San Francisco, CA 94143, USA 2Department of Paediatrics and Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, CB2 0QQ, UK 3Department of Neurology, Medical Faculty Mannheim, University of Heidelberg, 68167 Mannheim, Germany 4Department of Pediatrics/Neonatology, University of California, San Francisco, San Francisco, CA 94158, USA 5Department of Neurology, University of California, San Francisco, San Francisco, CA 94158, Europe PMC Funders Author Manuscripts USA 6Institute of Neuroimmunology and Multiple Sclerosis, Center for Molecular Neurobiology Hamburg, University Medical Center Hamburg-Eppendorf,
    [Show full text]
  • Anti-HIF1AN Antibody (ARG56304)
    Product datasheet [email protected] ARG56304 Package: 100 μl anti-HIF1AN antibody Store at: -20°C Summary Product Description Rabbit Polyclonal antibody recognizes HIF1AN Tested Reactivity Hu, Ms Tested Application ICC/IF, WB Host Rabbit Clonality Polyclonal Isotype IgG Target Name HIF1AN Antigen Species Human Immunogen Recombinant protein of Human HIF1AN Conjugation Un-conjugated Alternate Names Factor inhibiting HIF-1; FIH-1; Hypoxia-inducible factor asparagine hydroxylase; Hypoxia-inducible factor 1-alpha inhibitor; EC 1.14.11.n4; EC 1.14.11.30; FIH1 Application Instructions Application table Application Dilution ICC/IF 1:50 - 1:200 WB 1:500 - 1:2000 Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. Positive Control MCF7 Calculated Mw 40 kDa Properties Form Liquid Purification Affinity purification with immunogen. Buffer PBS (pH 7.3), 0.02% Sodium azide and 50% Glycerol. Preservative 0.02% Sodium azide Stabilizer 50% Glycerol Storage instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. Note For laboratory research only, not for drug, diagnostic or other use. www.arigobio.com 1/2 Bioinformation Database links GeneID: 319594 Mouse GeneID: 55662 Human Swiss-port # Q8BLR9 Mouse Swiss-port # Q9NWT6 Human Gene Symbol HIF1AN Gene Full Name hypoxia inducible factor 1, alpha subunit inhibitor Function Hydroxylates HIF-1 alpha at 'Asp-803' in the C-terminal transactivation domain (CAD).
    [Show full text]
  • Comparative Transcriptomics Reveals Similarities and Differences
    Seifert et al. BMC Cancer (2015) 15:952 DOI 10.1186/s12885-015-1939-9 RESEARCH ARTICLE Open Access Comparative transcriptomics reveals similarities and differences between astrocytoma grades Michael Seifert1,2,5*, Martin Garbe1, Betty Friedrich1,3, Michel Mittelbronn4 and Barbara Klink5,6,7 Abstract Background: Astrocytomas are the most common primary brain tumors distinguished into four histological grades. Molecular analyses of individual astrocytoma grades have revealed detailed insights into genetic, transcriptomic and epigenetic alterations. This provides an excellent basis to identify similarities and differences between astrocytoma grades. Methods: We utilized public omics data of all four astrocytoma grades focusing on pilocytic astrocytomas (PA I), diffuse astrocytomas (AS II), anaplastic astrocytomas (AS III) and glioblastomas (GBM IV) to identify similarities and differences using well-established bioinformatics and systems biology approaches. We further validated the expression and localization of Ang2 involved in angiogenesis using immunohistochemistry. Results: Our analyses show similarities and differences between astrocytoma grades at the level of individual genes, signaling pathways and regulatory networks. We identified many differentially expressed genes that were either exclusively observed in a specific astrocytoma grade or commonly affected in specific subsets of astrocytoma grades in comparison to normal brain. Further, the number of differentially expressed genes generally increased with the astrocytoma grade with one major exception. The cytokine receptor pathway showed nearly the same number of differentially expressed genes in PA I and GBM IV and was further characterized by a significant overlap of commonly altered genes and an exclusive enrichment of overexpressed cancer genes in GBM IV. Additional analyses revealed a strong exclusive overexpression of CX3CL1 (fractalkine) and its receptor CX3CR1 in PA I possibly contributing to the absence of invasive growth.
    [Show full text]
  • Single-Cell Transcriptomes Reveal a Complex Cellular Landscape in the Middle Ear and Differential Capacities for Acute Response to Infection
    fgene-11-00358 April 9, 2020 Time: 15:55 # 1 ORIGINAL RESEARCH published: 15 April 2020 doi: 10.3389/fgene.2020.00358 Single-Cell Transcriptomes Reveal a Complex Cellular Landscape in the Middle Ear and Differential Capacities for Acute Response to Infection Allen F. Ryan1*, Chanond A. Nasamran2, Kwang Pak1, Clara Draf1, Kathleen M. Fisch2, Nicholas Webster3 and Arwa Kurabi1 1 Departments of Surgery/Otolaryngology, UC San Diego School of Medicine, VA Medical Center, La Jolla, CA, United States, 2 Medicine/Center for Computational Biology & Bioinformatics, UC San Diego School of Medicine, VA Medical Center, La Jolla, CA, United States, 3 Medicine/Endocrinology, UC San Diego School of Medicine, VA Medical Center, La Jolla, CA, United States Single-cell transcriptomics was used to profile cells of the normal murine middle ear. Clustering analysis of 6770 transcriptomes identified 17 cell clusters corresponding to distinct cell types: five epithelial, three stromal, three lymphocyte, two monocyte, Edited by: two endothelial, one pericyte and one melanocyte cluster. Within some clusters, Amélie Bonnefond, Institut National de la Santé et de la cell subtypes were identified. While many corresponded to those cell types known Recherche Médicale (INSERM), from prior studies, several novel types or subtypes were noted. The results indicate France unexpected cellular diversity within the resting middle ear mucosa. The resolution of Reviewed by: Fabien Delahaye, uncomplicated, acute, otitis media is too rapid for cognate immunity to play a major Institut Pasteur de Lille, France role. Thus innate immunity is likely responsible for normal recovery from middle ear Nelson L. S. Tang, infection. The need for rapid response to pathogens suggests that innate immune The Chinese University of Hong Kong, China genes may be constitutively expressed by middle ear cells.
    [Show full text]
  • A High Throughput, Functional Screen of Human Body Mass Index GWAS Loci Using Tissue-Specific Rnai Drosophila Melanogaster Crosses Thomas J
    Washington University School of Medicine Digital Commons@Becker Open Access Publications 2018 A high throughput, functional screen of human Body Mass Index GWAS loci using tissue-specific RNAi Drosophila melanogaster crosses Thomas J. Baranski Washington University School of Medicine in St. Louis Aldi T. Kraja Washington University School of Medicine in St. Louis Jill L. Fink Washington University School of Medicine in St. Louis Mary Feitosa Washington University School of Medicine in St. Louis Petra A. Lenzini Washington University School of Medicine in St. Louis See next page for additional authors Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs Recommended Citation Baranski, Thomas J.; Kraja, Aldi T.; Fink, Jill L.; Feitosa, Mary; Lenzini, Petra A.; Borecki, Ingrid B.; Liu, Ching-Ti; Cupples, L. Adrienne; North, Kari E.; and Province, Michael A., ,"A high throughput, functional screen of human Body Mass Index GWAS loci using tissue-specific RNAi Drosophila melanogaster crosses." PLoS Genetics.14,4. e1007222. (2018). https://digitalcommons.wustl.edu/open_access_pubs/6820 This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact [email protected]. Authors Thomas J. Baranski, Aldi T. Kraja, Jill L. Fink, Mary Feitosa, Petra A. Lenzini, Ingrid B. Borecki, Ching-Ti Liu, L. Adrienne Cupples, Kari E. North, and Michael A. Province This open access publication is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/open_access_pubs/6820 RESEARCH ARTICLE A high throughput, functional screen of human Body Mass Index GWAS loci using tissue-specific RNAi Drosophila melanogaster crosses Thomas J.
    [Show full text]
  • ANKDD1A May Serve As a Critical Gene in the Immune Microenvironment of Breast Cancer
    1367 Original Article ANKDD1A may serve as a critical gene in the immune microenvironment of breast cancer Ping Zhao1#, Yang Fu2#, Xin Yang3, Hiseein Ali Abdoulaye4, Ritika Rauniyar4, Jing Peng5, Maohua Wang1, Huiqiao Wang4, Minjie Ning4, Ying Chen4^, Yunchao Huang4 1Department of Mammary Surgery I, The Third Affiliated Hospital of Kunming Medical University (Yunnan Cancer Hospital, Yunnan Cancer Center), Kunming, China; 2Department of Radiology, The First People’s Hospital of Kunming, Kunming, China; 3Department of Blood Transfusion, The First People’s Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, China; 4Department of Thoracic Surgery I, The Third Affiliated Hospital of Kunming Medical University (Yunnan Cancer Hospital, Yunnan Cancer Center), The International Cooperation Key Laboratory of Regional Tumor in High Altitude Area, Kunming, China; 5Anesthesiology Department, The Third Affiliated Hospital of Kunming Medical University (Yunnan Cancer Hospital, Yunnan Cancer Center), The International Cooperation Key Laboratory of Regional Tumor in High Altitude Area, Kunming, China Contributions: (I) Conception and design: P Zhao, Y Fu, Y Chen, Y Huang; (II) Administrative support: Y Chen, Y Huang; (III) Provision of study materials or patients: X Yang, HA Abdoulaye, R Rauniyar, J Peng; (IV) Collection and assembly of data: M Wang, H Wang, M Ning; (V) Data analysis and interpretation: P Zhao, Y Fu, Y Chen, Y Huang, J Peng; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. #These authors contributed equally to this work. Correspondence to: Ying Chen. Department of Thoracic Surgery, The Third Affiliated Hospital of Kunming Medical University (Yunnan Cancer Hospital, Yunnan Cancer Center), No.
    [Show full text]
  • In Inhibiting HIF- 1 Transcriptional Activity in Glioblastoma Multiforme
    The Role of Factor Inhibiting HIF (FIH-1) in Inhibiting HIF- 1 Transcriptional Activity in Glioblastoma Multiforme Enfeng Wang1., Chunyang Zhang2., Navatha Polavaram3., Fengming Liu4, Gang Wu1¤, Mark A. Schroeder5, Julie S. Lau1, Debabrata Mukhopadhyay1, Shi-Wen Jiang6,7, Brian Patrick O’Neill1, Kaustubh Datta3*, Jinping Li6,7* 1 Department of Biochemistry and Molecular Biology, Mayo Clinic Cancer Center, Rochester, Minnesota, United States of America, 2 Department of Neuro-Surgery, the First Affiliated Hospital of Baotou Medical College, Baotou, China, 3 Department of Biochemistry and Molecular Biology and Eppley Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska, United States of America, 4 Department of Research and Development, Guangxi Medicinal Botanical Institute, Nanning, Guangxi, China, 5 Department of Radiation Oncology, Mayo Clinic Cancer Center, Rochester, Minnesota, United States of America, 6 Department of Biomedical Science, Mercer University School of Medicine, Savannah, Georgia, United States of America, 7 Department of Obstetrics and Gynecology, Memorial Health Hospital, Savannah, Georgia, United States of America Abstract Glioblastoma multiforme (GBM) accounts for about 38% of primary brain tumors in the United States. GBM is characterized by extensive angiogenesis induced by vascular growth factors and cytokines. The transcription of these growth factors and cytokines is regulated by the Hypoxia-Inducible-Factor-1(HIF-1), which is a key regulator mediating the cellular response to hypoxia. It is known that Factor Inhibiting HIF-1, or FIH-1, is also involved in the cellular response to hypoxia and has the capability to physically interact with HIF-1 and block its transcriptional activity under normoxic conditions. Delineation of the regulatory role of FIH-1 will help us to better understand the molecular mechanism responsible for tumor growth and progression and may lead to the design of new therapies targeting cellular pathways in response to hypoxia.
    [Show full text]
  • Downregulation of Microrna-31 Inhibits Proliferation and Induces Apoptosis by Targeting HIF1AN in Human Keloid
    www.impactjournals.com/oncotarget/ Oncotarget, 2017, Vol. 8, (No. 43), pp: 74623-74634 Research Paper Downregulation of microRNA-31 inhibits proliferation and induces apoptosis by targeting HIF1AN in human keloid Juan Zhang1,2,*, Dan Xu1,*, Na Li1,*, Yan Li1,*, Yongjing He3, Xingbo Hu4, Lechun Lyu1,2 and Li He1 1Department of Dermatology, the First Affiliated Hospital of Kunming Medical University, Kunming, China 2Department of Physiology, Kunming Medical University, Kunming, China 3Department of Plastic Surgery, Second Affiliated Hospital of Kunming Medical University, Kunming, China 4Department of Orthopedics, the First People’s Hospital of Kunming, Kunming, China *Authors contributed equally to this work Correspondence to: Lechun Lyu, email: [email protected] Li He, email: [email protected] Keywords: keloid, microRNA-31, proliferation, apoptosis, cell cycle Received: April 26, 2017 Accepted: July 12, 2017 Published: August 16, 2017 Copyright: Zhang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACT microRNAs (miRNAs) play a pivotal role in the regulation of cell proliferation and apoptosis in keloid scarring. Integrative analysis of the previous miRNA microarray revealed miRNA-31 was among the most frequently altered miRNAs in keloid and hypertrophic scar. Using qRT-PCR, we further validated miRNA-31 was increased in keloid tissues and keloid-derived fibroblasts. Moreover, downregulation of miRNA-31 inhibited the cell proliferation, induced the cell apoptosis and disturbed the cell cycle progression by targeting HIF1AN, a negative modulator of hypoxia inducible factor 1.
    [Show full text]
  • Comprehensive Biological Information Analysis of PTEN Gene in Pan-Cancer
    Comprehensive biological information analysis of PTEN gene in pan-cancer Hang Zhang Shanghai Medical University: Fudan University https://orcid.org/0000-0002-5853-7754 Wenhan Zhou Shanghai Medical University: Fudan University Xiaoyi Yang Shanghai Jiao Tong University School of Medicine Shuzhan Wen Shanghai Medical University: Fudan University Baicheng Zhao Shanghai Medical University: Fudan University Jiale Feng Shanghai Medical University: Fudan University Shuying Chen ( [email protected] ) https://orcid.org/0000-0002-9215-9777 Primary research Keywords: PTEN, correlated genes, TCGA, GEPIA, UALCAN, GTEx, expression, cancer Posted Date: April 12th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-388887/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/21 Abstract Background PTEN is a multifunctional tumor suppressor gene mutating at high frequency in a variety of cancers. However, its expression in pan-cancer, correlated genes, survival prognosis, and regulatory pathways are not completely described. Here, we aimed to conduct a comprehensive analysis from the above perspectives in order to provide reference for clinical application. Methods we studied the expression levels in cancers by using data from TCGA and GTEx database. Obtain expression box plot from UALCAN database. Perform mutation analysis on the cBioportal website. Obtain correlation genes on the GEPIA website. Construct protein network and perform KEGG and GO enrichment analysis on the STRING database. Perform prognostic analysis on the Kaplan-Meier Plotter website. We also performed transcription factor prediction on the PROMO database and performed RNA-RNA association and RNA-protein interaction on the RNAup Web server and RPISEq.
    [Show full text]
  • Meta-Analysis of Gene Expression in Individuals with Autism Spectrum Disorders
    Meta-analysis of Gene Expression in Individuals with Autism Spectrum Disorders by Carolyn Lin Wei Ch’ng BSc., University of Michigan Ann Arbor, 2011 A THESIS SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF Master of Science in THE FACULTY OF GRADUATE AND POSTDOCTORAL STUDIES (Bioinformatics) The University of British Columbia (Vancouver) August 2013 c Carolyn Lin Wei Ch’ng, 2013 Abstract Autism spectrum disorders (ASD) are clinically heterogeneous and biologically complex. State of the art genetics research has unveiled a large number of variants linked to ASD. But in general it remains unclear, what biological factors lead to changes in the brains of autistic individuals. We build on the premise that these heterogeneous genetic or genomic aberra- tions will converge towards a common impact downstream, which might be reflected in the transcriptomes of individuals with ASD. Similarly, a considerable number of transcriptome analyses have been performed in attempts to address this question, but their findings lack a clear consensus. As a result, each of these individual studies has not led to any significant advance in understanding the autistic phenotype as a whole. The goal of this research is to comprehensively re-evaluate these expression profiling studies by conducting a systematic meta-analysis. Here, we report a meta-analysis of over 1000 microarrays across twelve independent studies on expression changes in ASD compared to unaffected individuals, in blood and brain. We identified a number of genes that are consistently differentially expressed across studies of the brain, suggestive of effects on mitochondrial function. In blood, consistent changes were more difficult to identify, despite individual studies tending to exhibit larger effects than the brain studies.
    [Show full text]